Blackstone Life Sciences

A private investment platform focused on the life sciences sector, funding late-stage development of medicines and medical technologies.

Venture Capital New York, United States Est. 2018
Visit website ↗
Last updated 2026-07-07
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
1
Rounds' value
$400.0M
total disclosed, rounds participated
Stages
Late-Stage

About

Blackstone Life Sciences (BXLS) is a leading private investment platform that collaborates with pharmaceutical, biotech, and medical technology companies. It focuses on funding the late-stage development of innovative medicines and medical technologies to address unmet medical needs and improve patients' lives. BXLS combines its clinical, commercial, and operational expertise with Blackstone's global network and capital.

Portfolio · 1

Teva Pharmaceuticals
A global pharmaceutical company specializing in generic drugs, specialty pharmaceuticals, and active pharmaceutical ingredients.
Led ★ 1 round $400.0M committed Latest: 2026-03
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)